Truqap is usually a kinase inhibitor that works by blocking pathways that aid the most cancers cells endure and expand, so minimizes most cancers progress. Truqap is from a category of medicines called an AKT inhibitor. Truqap been given FDA approval on November seventeen, 2023, just after good resu